Christopher van Tuyl, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 21,626 shares at $27.38 ($582K) on 2025-12-18, disclosed to the SEC on 2025-12-19.
Open-market sale of $582k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.78 | 8,529 | $228K | 39.3% |
| 2 | $26.78 | 8,529 | $228K | 39.3% |
| 3 | $27.38 | 2,284 | $63K | 10.7% |
| 4 | $27.38 | 2,284 | $63K | 10.7% |
| Total | $26.91 avg | 21,626 | $582K | 100% |
| Filing → |
| IMVT | SELL | 2026-07-10 | $48K | — | Filing → |
| IMVT | SELL | 2026-06-26 | $683K | — | Filing → |
| IMVT | SELL | 2026-06-22 | $93K | — | Filing → |